Magmaris Magnesium BRS: safety and performance of an advanced and innovative technology
Sponsored by Biotronik
Consult this session presented by M. Joner, W. Wijns and M.K.Y. Lee if you want to find out more about the best indication for patient selection in 2017, ultrathin, bioresorbable polymer sirolimus-eluting stents vs thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisatio; the new update on Dual Antiplatelet Therapy (DAPT) VALIDATE-SWEDEHEART, TROPICAL-ACS and RE-DUAL PCI from the ESC 2017 and more...
- To learn how Magmaris affects thrombogenicity
- To discuss on the best implantation techniques
- To review optimal indications and patient selection for Magmaris use